Results 241 to 250 of about 416,036 (340)

Polysaccharide‐Coated ETCA Nanoparticles Containing the Methoxyl Substituted Indole‐Thiazole Derivative and Their Antiproliferative Activity in Breast Cancer Cells

open access: yesJournal of Applied Polymer Science, EarlyView.
ABSTRACT Indole and thiazole derivatives have garnered significant attention due to their potent antitumor activities. Encapsulation of such derivatives into polymeric nanoparticles offers several advantages, including improved molecular stability and targeted delivery to tumor sites, thereby enhancing their antineoplastic potential.
José Cleberson Santos Soares   +4 more
wiley   +1 more source

Two cases of resected mediastinal malignant germ cell tumors following cisplatin, vinblastine, and bleomycin combination chemotherapy.

open access: bronze, 1987
Akira Hayashibe   +14 more
openalex   +2 more sources

Synthesis of BODIPY‐Linked N‐Heterocyclic Carbene Metal Complexes for Cancer Chemotheranostics and Catalysis Applications

open access: yesChemistry – An Asian Journal, EarlyView.
A simple and efficient design strategy for the synthesis of BODIPY‐linked N‐Heterocyclic Carbene Metal Complexes (Ag, Cu, Ni, Pd) is developed. Fluorescent BODIPY‐silver carbene complex is useful for cellular imaging and shows chemotheraputic anti‐cancer activity.
Shraddha SP Yadav   +6 more
wiley   +1 more source

The Stem Cell Transcription Factor OCT4 Silences Target DNA Methyltransferase 1 to Strengthen DNA Damage Response in Cisplatin‐Treated Gastric Cancer Cells

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT OCT4 plays a crucial role in the DNA damage response(DDR) mechanism, whereas cisplatin (CDDP) acts as an anti‐tumor agent by inducing DDR. This study aimed to investigate the role of OCT4 in regulating DNA methyltransferase 1 (DNMT1) in CDDP‐treated gastric cancer (GC).
Zhengzheng Yan   +6 more
wiley   +1 more source

Pharmacokinetics of teicoplanin in paediatric patients—A systematic review of current literature

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Background and Objective Teicoplanin is commonly used in children to treat gram‐positive infections and is sometimes used off‐label prophylactically in surgical or paediatric oncology settings. The pharmacokinetics (PK) of teicoplanin in children exhibit considerable variability, such as in critically ill children or those with renal impairment.
Noa E. Wijnen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy